Circadian activity of corticosterone in an animal model of depression: Response to muscarinic cholinergic stimulation

Physiology and Behavior

Volumn 100, Issue 4, 2010, Pages 311-315

  Bonilla Jaime, H ^a   Retana Marquez S ^a   Arteaga Silva, M ^a   Hernandez Gonzalez M ^b   Vazquez Palacios G ^c  

^a DEPARTAMENTO DE QUÍMICA   (Mexico)

^b UNIVERSITY OF GUADALAJARA   (Mexico)

^c UNIVERSIDAD AUTÓNOMA DE LA CIUDAD DE MÉXICO   (Mexico)

Author keywords

Acetylcholine; Animal models; Corticosterone; Depression; Fluoxetine; Oxotremorine

Indexed keywords

CHOLINERGIC RECEPTOR STIMULATING AGENT; CLOMIPRAMINE; CORTICOSTERONE; FLUOXETINE; OXOTREMORINE; ANTIDEPRESSANT AGENT; MUSCARINIC AGENT;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHOLINERGIC STIMULATION; CIRCADIAN RHYTHM; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; DEPRESSION; DISEASE MODEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; LIGHT DARK CYCLE; MALE; NONHUMAN; PRIORITY JOURNAL; STIMULUS RESPONSE; TIME; TREATMENT DURATION; ANIMAL; ANTAGONISTS AND INHIBITORS; BLOOD; CHEMICALLY INDUCED; DOSE RESPONSE; DRUG ADMINISTRATION; DRUG EFFECTS; FEMALE; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; NEWBORN; RAT; WISTAR RAT;

ANIMALS; ANIMALS, NEWBORN; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; BEHAVIOR, ANIMAL; CHOLINERGIC AGONISTS; CIRCADIAN RHYTHM; CLOMIPRAMINE; CORTICOSTERONE; DEPRESSION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; FLUOXETINE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; MUSCARINIC AGONISTS; OXOTREMORINE; PITUITARY-ADRENAL SYSTEM; RATS; RATS, WISTAR; TIME FACTORS;

EID: 77952956346     PISSN: 00319384     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.physbeh.2010.03.002     Document Type: Article

References (34)

1. Millan M.J. Multi-target strategies for the improved treatment of depressive states: conceptual foundations and neuronal substrates, drug discovery and therapeutic application. Pharmacol Ther 2006, 110(2):135-370.
2. Juruena F.M., Cleare J.A., Pariente M.C. The hypothalamic pituitary adrenal axis, glucocorticoid receptor function and relevance to depression. Rev Bras Psisquiatr 2004, 26(3):189-201.
3. Heuser I., Yassourides A., Holsboer F. The combined dexamethasone/CRH test: a refined laboratory test for psychiatric disorders. J Psychiatr Res 1994, 28(4):341-356.
4. Vijayakumar M., Subimal D. Clomipramine treatment in neonatal rats alters the brain acetylcholinesterase activity in adulthood. Neurosci Lett 2002, 330:119-121.
5. Vogel G.W., Hartley P., Neill D., Hagler M., Kors D. A new animal model of endogenous depression: a summary of present findings. Neurosci Biobehav Rev 1990, 14:85-91.
6. Hartley P., Neill D., Hagler M., Kors D., Vogel G. Procedure and age dependent hyperactivity in a new animal model of endogenous depression. Neurosci Biobehav Rev 1990, 14:69-72.
7. Bonilla-Jaime H., Retana-Marquez S., Velazquez-Moctezuma J. Pharmacological features of masculine sexual behavior in an animal model of depression. Pharmacol Biochem Behav 1998, 60:39-45.
8. Bhagya V., Srikumar B.N., Raju T.R., Shankaranarayana R. Neonatal clomipramine induced endogenous depression in rats is associated with learning impairment in adulthood. Behav Brain Res 2008, 187:190-194.
9. Dwyer S.M., Rosenwasser A.M. Neonatal clomipramine treatment, alcohol intake and circadian rhythms in rats. Psychopharmacology 1998, 138:176-183.
10. Prathiba J., Kumar K.B., Karanth K.S. Hyperactivity of hypothalamic pituitary axis in a neonatal clomipramine model of depression. J Neural Transm 1998, 105:1335-1339.
11. Prathiba J., Kumar K.B., Karanth K.S. Effects of chronic administration of imipramine on the hyperactivity of hypothalamic-pituitary-adrenal axis in neonatal clomipramine treated rats. Indian J Pharmacol 1999, 31:225-228.
12. Feenstra M.G., van Galen H., Te Riele P.J., Botterblom M.H., Mirmiran M. Decreased hypothalamic serotonin levels in adult rats treated neonatally with clomipramine. Pharmacol Biochem Behav 1996, 55(4):647-652.
13. Ogawa T., Mikuni M., Kuroda Y., Muncoka K., Mori K.J., Takahashi K. Effect of the altered serotoninergic signaling by neonatal treatment with 5, 7-dihidroxytriptamine, ritanserin or clomipramine on the adrenocortical stress response and the glucocorticoid receptor binding in the hippocampus in adult rats. J Neural Transm 1994, 96:113-123.
14. Calogero A.E., Gallucci W.T., Bernardini R., Saoutis C., Gold P.W., Chrousos G.P. Effect of cholinergic agonist and antagonist on rat hypothalamic corticotrophin-releasing hormone secretion in vitro. Neuroendocrinology 1988, 47:303-308.
15. Prathiba J., Kumar K.B., Karanth K.S. Effects of neonatal clomipramine on cholinergic receptor sensitivity and passive avoidance behavior in adult rats. J Neural Transm Gen Sect 1995, 100(2):93-99.
16. NORMA Oficial Mexicana NOM-062-ZOO-1999, Especificaciones técnicas para la producción, cuidado y uso de los animales de laboratorio http://www.fmvz.unam.mx/fmvz/principal/archivos/062ZOO.
17. Vázquez-Palacios G., Bonilla-Jaime H., Velázquez-Moctezuma J. Antidepressant effects of nicotine and fluoxetine in an animal model of depression induced by neonatal treatment with clomipramine. Prog Neuropsychopharmacol Biol Psychiatry 2005, 29:39-46.
18. Woodward J.H., Emery P.W. Determination of plasma corticosterone using high performance liquid chromatography. J Chromatogr 1987, 4119:280-284.
19. Ottenweller J.E., Pitman D.L., Natelson B.H. Repeated stress at the same time of day does not mimic timed feeding in its effects on the plasma corticosterone rhythm in rats. Chronobiologia 1987, 14(1):1-6.
20. Linkowski P., Mendlewicz J., Kerkhofs M., Leclercq R., Golstein J., Brasseur M., Copinschi G., Van Cauter E. 24-hour profiles of adrenocorticotropin, cortisol, and growth hormone in major depressive illness: effect of antidepressant treatment. J Clin Endocrinol Metab 1987, 65:141-152.
21. Ayensu W.K., Pucilowski O., Mason G.A., Overstreet D.H., Rezvani A.H., Janowsky D.S. Effects of chronic mild stress on serum complement activity, saccharin preference and corticosterone levels in Flinders lines of rats. Physiol Behav 1995, 57:165-169.
22. Koehl M., Barbazanges A., Le Moal M., Maccari S. Prenatal stress induces a phase advance of circadian corticosterone rhythm in adult rats which is prevented by postnatal stress. Brain Res 1997, 759:317-320.
23. Marcilhac A., Maurel D., Anglade G., Ixart G., Mekaouche M., Hery F., Siaud P. Effects of bilateral olfactory bulbectomy on circadian rhythms of ACTH, corticosterone, motor activity and body temperature in male rats. Arch Physiol Biochem 1997, 105:552-559.
24. Pariante C.M., Miller A.H. Glucocorticoid receptor in major depression: relevance to patophysiology and treatment. Biol Psychiatry 2001, 49:391-404.
25. Duncan G., Darin J., Stanley W., Carson, Breeseduncan G.R. Differential effects of chronic antidepressant treatment on swim stress- and fluoxetine-induced secretion of corticosterone and progesterone. J Pharmacol Exp Ther 1998, 285:579-587. [Weber et al, 2006].
26. Weber C.C., Eckert G.P., Muller W.E. Effects of antidepressants on the brain/plasma distribution of corticosterone. Neuropsychopharmacology 2006, 31:2443-2448.
27. Vazquez-Palacios G., Bonilla-Jaime H., Velázquez-Moctezuma J. Antidepressant-like effects of the acute and chronic administration of nicotine in the rat forced swimming test and its interaction with flouxetine. Pharmacol Biochem Behav 2004, 78:165-169.
28. Pariante C.M., Kim R.B., Makoff A., Kerwin R.W. Antidepressant fluoxetine enhances glucocorticoid receptor function in vitro by modulating membrane steroid transporters. Br J Pharmacol 2003, 139(6):1111-1118.
29. Pariante C.M., Thomas S.A., Lovestone S., Makoff A., Kerwin R.W. Do antidepressants regulate how cortisol affects the brain?. Psychoneuroendocrinology 2004, 29(4):423-447.
30. Prathiba J., Kumar K.B., Karanth K.S. Effects of REM sleep deprivation on cholinergic receptor sensitivity and passive avoidance behavior in clomipramine model of depression. Brain Res 2000, 867(1-2):243-245.
31. Kafka M.S., Wirz-Justice A., Naber D., Weher T.A. Circadian acetylcholine receptor rhythm in rat brain and its modification by imipramine. Neuropharmacology 1981, 20:241-425.
32. Bugajski J., Gadek-Michalska A., Bugajski A.J. A single corticosterone pretreatment inhibits the hypothalamic-pituitary-adrenal responses to adrenergic and cholinergic stimulation. J Physiol Pharmacol 2001, 52(2):313-324.
33. Pullia D., Amato F.D., Mele A., Oliverio A., Zocchi A., Pavone F. Time-related effects of stress on cholinergic sensitivity. Brain Res 1966, 743:333-336.
34. Rhodes M.E., Billings T.E., Czambel R.K., Rubin R.T. Pituitary-adrenal responses to cholinergic stimulation and acute mild stress are differentially elevated in male and female M(2) muscarinic receptor knockout mice. J Neuroendocrinol 2005, 17(12):817-826.